endolinx Medical News about Hyperparathyroidism

Endocrinology

Become a Member Today!

Email
Password
Remember me
Forgot your Password?
Invite Code?

Home
General Endocrinology

Messages

Conferences

Jobs

Newsletters

My Library

Topics in
Endocrinology

Adrenal Glands

Atherosclerosis/Lipids

Basic Science/Genetics

Bone Metabolism

Diabetes

Diagnostics

Economics of Medicine

Endocrine Oncology

Fetal Development

Hypertension

Metabolism and Growth

Neuroendocrinology

Obesity

Pediatric Endocrinology

Pharmacology/kinetics

Popular Press

Reproductive
Endocrinology

Thyroid/Parathyroid

Help

Resource Center

RSS News Feeds

Send Newsletter
to a Friend

Sponsor

FDA Update: Thyrotropin Approved For Thyroid Cancer Ablation
Tracy Hampton, PhD, MDLinx Oncology

See all

Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website

Combined therapy with cinacalcet and low doses of vitamin D sterols in patients with moderate to severe secondary hyperparathyroidism
Nephrology Dialysis Transplantation, 07/02/08

Email This Article

Save in My Library

Free Abstract

Block GA et al. - Among subjects with moderate to severe sHPT undergoing haemodialysis, combined therapy with cinacalcet and low doses of vitamin D sterols improved achievement of the biochemical targets for CKD-MBD recommended by the KDOQITM guidelines.

Sponsor

--- THYROID/PARATHYROID TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email

Effect of Cinacalcet on Hypercalcemia and Bone Mineral Density in Renal Transplanted Patients With Secondary Hyperparathyroidism
Transplantation, 08/13/08

Long-term prognosis of medullary thyroid carcinoma
Clinical Endocrinology, 08/21/08

Predictors of level V metastasis in well-differentiated thyroid cancer
Head & Neck, 08/29/08

...All of Thyroid/Parathyroid